    <SEC-DOCUMENT>0000950170-23-016305-index.html : 20230501
    <SEC-HEADER>0000950170-23-016305.hdr.sgml : 20230501
    <ACCEPTANCE-DATETIME>20230501165104
    ACCESSION NUMBER:		0000950170-23-016305
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230501
    DATE AS OF CHANGE:		20230501
    EFFECTIVENESS DATE:		20230501

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Eledon Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001404281
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36620
    		FILM NUMBER:		23874596

    	BUSINESS ADDRESS:
    		STREET 1:		19900 MACARTHUR BLVD.
    		STREET 2:		SUITE 550
    		CITY:			IRVINE
    		STATE:			CA
    		ZIP:			92612
    		BUSINESS PHONE:		949-238-8090

    	MAIL ADDRESS:
    		STREET 1:		19900 MACARTHUR BLVD.
    		STREET 2:		SUITE 550
    		CITY:			IRVINE
    		STATE:			CA
    		ZIP:			92612

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Novus Therapeutics, Inc.
    		DATE OF NAME CHANGE:	20170511

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
    		DATE OF NAME CHANGE:	20070622
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>elsn-2023-proxy-ars_fili.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: elsn-2023-proxy-ars_fili.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>